![Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Glargine 100 U/mL in Asia Pacific Insulin‐Naïve People with Type 2 Diabetes: The EDITION AP Randomised Controlled Trial]()
Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Glargine 100 U/mL in Asia Pacific Insulin‐Naïve People with Type 2 Diabetes: The EDITION AP Randomised Controlled TrialJi, Linong; Kang, Eun Seok; Dong, XiaoLin; Li, Ling; Yuan, GuoYue; Shang, Shuhua; Niemoeller, Elisabeth; Ji, Linong; Bi, Yan; Yang, Jinkui; Li, Yanbing; Li, Ling; Xu, Xiangjin; Shi, Bingyin; Li, Wei; Qin, Guijun; Lu, Yibing; Sun, Li; Xue, Yaoming; Gao, Jianbo; Hong, Tianpei; Liu, Jun; Dong, Xiaolin; Zhang, Fan; Li, Yiming; Li, Shuying; Zhang, Qiuling; Li, Dongmei; Sun, Qingyuan; Tang, Xulei; Yuan, Guoyue; Fang, Hui; Deng, Hongyan; Wang, Guixia; Li, Xuejun; Kuang, Jian; Lai, Xiaoyang; Guo, Xiaohui; Lin, Xiaohong; Zhang, Qiao; Li, Yan; Lin, Jingna; Liu, Jingdong; Ye, Shandong; Yang, Tao; Park, Cheol Young; Chung, Choon Hee; Kang, Jun Goo; Kim, Chul Sik; Cho, Young Min; Kim, In Joo; Kang, Eun Seok; Lee, Wooje; Han, Kyung Ah; Kim, Jae Hyeon; Kim, Sang Yong; Kim, Mikyung; Lee, Chang Beom; Ching‐Chu, Chen; Ju‐Ying, Jiang; Chen‐Ling, Huang; Ming‐Nan, Chien · Diabetes, Obesity and Metabolism · 2019